Arya News - Food and Drug Administration has approved Vera Therapeutics` drug to treat patients with a potentially life-threatening kidney disease, the regulator said on Tuesday, sending its shares up 6. The ...
July 7 (Reuters) - The U.S. Food and Drug Administration has approved Vera Therapeutics" drug to treat patients with a potentially life-threatening kidney disease, the regulator said on Tuesday, sending its shares up 6.2% in afternoon trading.
The drug Trutakna is a self-administered injectable treatment approved for patients with immunoglobulin A nephropathy, also known as Berger"s disease, which causes abnormal protein buildup in the kidneys and could eventually lead to the organ"s failure.
Trutakna targets the immune-system proteins BAFF and APRIL, which are involved in the production of disease-causing antibodies in IgA nephropathy and other autoimmune disorders.
(Reporting by Siddhi Mahatole and Puyaan Singh in Bengaluru; Editing by Vijay Kishore)